Wednesday, 9 November 2016

Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - United States; New Report Launched

Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - United States

Cytomegalovirus (CMV) Infection - Epidemiology Insights-2023- United States” Reports provides an overview of the disease and the historical and forecasted epidemiological data of the Cytomegalovirus (CMV) Infection for the United States for 2013-2023.

The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecast for these high risk categories have also been taken into consideration. Out of all these high risk categories, CMV is more prevalent among the Transplant patients than HIV patients and Infants. As per Publisher’s estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope
  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • Identifying patient populations in the United States Cytomegalovirus (CMV) Infection market
  • The Report covers the detailed historical and forecasted epidemiological data covering United States from 2013-2023.

Spanning over 60 pages, 8 Tables and 8 Figures Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - United States” report covers Cytomegalovirus Infections, Disease Overview, Symptoms of cytomegalovirus (CMV) Infection, Epidemiology and Patient Population, Report Methodology, Appendix.

For more information Visit at: http://mrr.cm/3ms

Related Reports;

Cytomegalovirus (CMV) Infection- Epidemiology Insights-2023- EU5 - Visit at - http://mrr.cm/3me

Cytomegalovirus (CMV) Infection - Epidemiology Insights-2023-Japan - Visit at - http://mrr.cm/3mn

No comments:

Post a Comment

Note: only a member of this blog may post a comment.